Exelixis director granted 8,367 RSUs

Eckhardt Sue Gail reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Eckhardt Sue Gail reported acquisition or exercise transactions in this Form 4 filing.

EXELIXIS, INC. director Sue Gail Eckhardt received a grant of 8,367 restricted stock units on May 27, 2026 under the company’s 2017 Equity Incentive Plan. Each RSU represents one share of common stock and will vest in full on May 27, 2027 if she remains in continuous service. Following this award, she holds 25,891 shares of common stock, including 16,079 shares that will be issued upon vesting of outstanding RSUs.

Insider Trade Summary

Grant/Award: 8,367 shares

Grant/Award 1 txn

Insider Eckhardt Sue Gail

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	8,367	$0.00	$0.00

Holdings After Transaction: Common Stock — 25,891 shares (Direct)

Footnotes (2)

1. F1. Represents restricted stock units ("RSUs") granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. Each RSU is the economic equivalent of one share of Exelixis, Inc. common stock ("Common Stock"). The RSUs will vest as to 100% of the shares subject to the RSU award on May 27, 2027, subject to the Reporting Person's continuous service through that date.
2. F2. Includes 16,079 shares of Common Stock that will be issued to the Reporting Person upon vesting of RSUs.

Key Figures

RSUs granted: 8,367 RSUs Shares after transaction: 25,891 shares Unvested RSU-related shares: 16,079 shares +2 more

5 metrics

RSUs granted 8,367 RSUs Award on May 27, 2026 under 2017 Equity Incentive Plan

Shares after transaction 25,891 shares Total common stock holdings following RSU grant

Unvested RSU-related shares 16,079 shares Shares to be issued upon vesting of outstanding RSUs

Vesting date May 27, 2027 100% of new RSU award vests on this date

Grant price $0.0000 per share Compensation grant, no purchase price paid for RSUs

Key Terms

restricted stock units ("RSUs"), 2017 Equity Incentive Plan, economic equivalent, continuous service

4 terms

restricted stock units ("RSUs") financial

"Represents restricted stock units ("RSUs") granted to the Reporting Person"

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

2017 Equity Incentive Plan financial

"granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan"

economic equivalent financial

"Each RSU is the economic equivalent of one share of Exelixis, Inc. common stock"

continuous service financial

"will vest as to 100% of the shares subject to the RSU award on May 27, 2027, subject to the Reporting Person's continuous service through that date"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Exelixis (EXEL) director Sue Gail Eckhardt report in this Form 4?

She reported receiving 8,367 restricted stock units as a grant. The RSUs were awarded under Exelixis’ 2017 Equity Incentive Plan and are compensation-related, not an open-market stock purchase or sale.

When do Sue Gail Eckhardt’s new 8,367 Exelixis RSUs vest?

The 8,367 RSUs will vest 100% on May 27, 2027. Vesting is contingent on her continuous service with Exelixis through that date, meaning she must remain in her role until then to receive the shares.

How many Exelixis (EXEL) shares does Sue Gail Eckhardt hold after this RSU grant?

After the grant, she holds 25,891 shares of Exelixis common stock. This total includes 16,079 shares that will be issued in the future when her previously granted RSUs vest, assuming vesting conditions are met.

Are Sue Gail Eckhardt’s 8,367 Exelixis RSUs equivalent to common stock now?

Each RSU is economically equivalent to one share of Exelixis common stock. However, the actual shares will only be issued when the RSUs vest on May 27, 2027, subject to her continuous service with the company.

Was there any open-market buying or selling of Exelixis (EXEL) stock in this Form 4?

No, this Form 4 reflects a grant of restricted stock units at no purchase price. The transaction is classified as a grant or award acquisition, not an open-market buy or sell of Exelixis shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/29/2026 - 05:43 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Eckhardt Sue Gail

(Last) (First) (Middle)

C/O EXELIXIS, INC.

1851 HARBOR BAY PARKWAY

(Street)

ALAMEDA CALIFORNIA 94502

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
EXELIXIS, INC. [ EXEL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/27/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/27/2026		A		8,367(1)	A	$0	25,891(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted stock units ("RSUs") granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. Each RSU is the economic equivalent of one share of Exelixis, Inc. common stock ("Common Stock"). The RSUs will vest as to 100% of the shares subject to the RSU award on May 27, 2027, subject to the Reporting Person's continuous service through that date.

2. Includes 16,079 shares of Common Stock that will be issued to the Reporting Person upon vesting of RSUs.

Remarks:

	/s/ Nina Ayer, Attorney in Fact	05/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)